Details.
Professional advisory service for pharmaceutical companies that combines clinical, economic and humanistic evidence to evaluate asset value, support business development and investment decisions, identify payer-relevant endpoints and instruments, prioritise indication development, and craft pricing and market access strategies. Akceso gathers information from markets, governments, health institutions and other stakeholders, using local pharmaceutical landscape expertise and industry data.